CSO and co-founder
NANJING, Jiangsu, China (People's Republic)
Xiaoling Li, Ph.D. is a Professor of Pharmaceutics and Associate Dean of Graduate Education and Research in Thomas J. Long School of Pharmacy and Health Sciences at the University of the Pacific. Dr. Li is a Fellow of AAPS and AIMBE. Dr. Li obtained his Ph.D. in Pharmaceutics in 1991 from the University of Utah under the guidance of Dr. Sung Wan Kim. Prior to his academic career, he was a postdoctoral research fellow at Ciba-Geigy Corp (now Novartis). Dr. Li’s research interest areas include innovative formulation development using 3D printing technology, targeting drug delivery, antibody mimics, drug transport across biological membranes, and application of physicochemical concepts to novel dosage form design. He holds 6 patents with 42 patent applications pending and has published more than 90 papers/book chapters, over 160 abstracts/presentations, and two books. Dr. Li received CRS Outstanding Paper Award for the Journal of Controlled Release in 1992, and is the recipient of AAPS Outstanding Educator Award in 2015. Dr. Li co-founded two companies, Formurex, Inc., a formulation development company in 2006 and Triastek, a 3D printing pharmaceutical company in 2015. He works closely with the pharmaceutical industry and provides consultation for product development to various pharmaceutical companies.